Clariant inks cellulosic biodiesel pact with ExxonMobil/REGSwiss fine chemicals specialist Clariant has hammered out a R&D pact with ExxonMobil and Renewable Energy Group (REG) Inc to combine technologies in order of producing biodiesel from cellulose&n … more ➔
IMI launches €80m callThe Innovative Medicines Initiative II has earmarked €80m for pre-competetive research improving the pharmaceutical industry’s productivity. more ➔
AMR: Novo Holdings funds companies with €18mNovo Holdings has invested €18m from its €135m REPAIR Impact Fund into four companies. more ➔
Boehringer expands neurology activitiesBoehringer Ingelheim has expanded its 2014 R&D collaboration with the BioMed X Innovation Center (Heidelberg, Germany) to find new treatment approaches for early intervention of psychiatric dise … more ➔
New target for lung fibrosis discoveredCanadian and Finnish researchers have demonstrated that long immune cell contact to lung tissue turns tissue repair into fibrosis. more ➔
Valneva inks $59m JE vaccine supply contractFrench vaccine specialist Valneva SE has inked a supply contract with the US Department of Defense for IXIARO its Japanese encephalitis (JE). more ➔
VTT turn waste into biofuels and chemicalsResearchers at VTT Technical Research Centre of Finland Ltd have presented a new gasification-based technique to turn forest industry byproducts into transport fuels and chemicals. more ➔
Tissue specific tumour transition needs few cellsGerman researchers have modeled when cellular alterations inevitably lead to the development of cancer. The transition is tissue-specific and needs only a few cells. more ➔
Drug dissociates metastasis precursors in bloodA team of Swiss researchers has identified Na+/K+-ATPase blockers as candidate drugs capable to prevent formation of metastases. In blood, the repurposed drugs identified in a screening dissociated … more ➔
Policymakers take no action after ECJ mutagenesis rulingIn summer the European Court of Justice (ECJ) ruled that crops created by biological mutagenesis techniques fall under EU GMO legislation. Germany’s government and the European Parliament see no need … more ➔
